NOVRQJGWQGGSLJ-WCJQCITJSA-N
C31H30F8N4O7 — CID 159842418
Data last refreshed: (MolForge compound catalog, from PubChem)
About NOVRQJGWQGGSLJ-WCJQCITJSA-N
NOVRQJGWQGGSLJ-WCJQCITJSA-N (PubChem CID 159842418) has the molecular formula C31H30F8N4O7 and a molecular weight of 722.59 g/mol. Its IUPAC name is (2S)-2-(3-fluorophenyl)-3-[[(3S)-3-(3-fluorophenyl)-3-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-ylmethylamino)propanoyl]amino]propanoic acid;bis(2,2,2-trifluoroacetic acid).
Molecular Properties
| Compound Name | NOVRQJGWQGGSLJ-WCJQCITJSA-N |
|---|---|
| PubChem CID | 159842418 |
| Molecular Formula | C31H30F8N4O7 |
| Molecular Weight | 722.59 g/mol |
| Exact Mass | 722.20 |
| IUPAC Name | (2S)-2-(3-fluorophenyl)-3-[[(3S)-3-(3-fluorophenyl)-3-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-ylmethylamino)propanoyl]amino]propanoic acid;bis(2,2,2-trifluoroacetic acid) |
| SMILES | O=C(C[C@H](NCc1ccc2c(n1)NCCC2)c1cccc(F)c1)NC[C@@H](C(=O)O)c1cccc(F)c1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F |
| InChI | InChI=1S/C27H28F2N4O3.2C2HF3O2/c28-20-7-1-4-18(12-20)23(27(35)36)16-32-25(34)14-24(19-5-2-8-21(29)13-19)31-15-22-10-9-17-6-3-11-30-26(17)33-22;2*3-2(4,5)1(6)7/h1-2,4-5,7-10,12-13,23-24,31H,3,6,11,14-16H2,(H,30,33)(H,32,34)(H,35,36);2*(H,6,7)/t23-,24+;;/m1../s1 |
| InChIKey | NOVRQJGWQGGSLJ-WCJQCITJSA-N |
| XLogP | 5.19 |
| TPSA | 177.95 Ų |
| H-Bond Donors | 6 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 10 |
| Heavy Atoms | 50 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 722.59 |
| LogP ≤ 5 | 5.19 |
| H-Bond Donors ≤ 5 | 6 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 159842418 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.